Revvity (RVTY) has had a dynamic performance in the past fiscal periods. The company's
Q1 and Q3 earnings and revenues have consistently surpassed estimates. In Q1 and Q4, EPS views were also effectively beaten. RVTY recently reported a
Quarterly Dividend. Major investment firms, including
Apollon Wealth Management, Charles Schwab Investment Management, Teacher Retirement System of Texas, and Amalgamated Bank have seized this opportunity to secure their own positions. The organization recently expanded its portfolio with a
new system for Autoimmune Diagnostics. Despite the trend of stock share prices dipping, RVTY's shareholder base remains strong with 80% of ownership held by institutional shareholders. However, recent updates reveal a
26% loss for shareholders over a single year. RVTY is navigating this hurdle by initiating a
reorganization plan. Meanwhile, strategic insights into SWOT are being analysed. In a shocking reveal, a complaint and
injunctive relief have been sought against Cloud Software Group. In light of recent events, RVTY Share prices have showed a downward trend, however TD Cowen raised RVTY’s price to $130.00.
Revvity RVTY News Analytics from Mon, 26 Jul 2021 07:00:00 GMT to Thu, 16 May 2024 12:58:14 GMT -
Rating -3
- Innovation 5
- Information 8
- Rumor -4
